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Abstract
Respiratory failure and death in East Coast Fever (ECF), a clinical syndrome of African cat-
tle caused by the apicomplexan parasite Theileria parva, has historically been attributed to
pulmonary infiltration by infected lymphocytes. However, immunohistochemical staining of
tissue from T. parva infected cattle revealed large numbers of CD3- and CD20-negative
intralesional mononuclear cells. Due to this finding, we hypothesized that macrophages
play an important role in Theileria parva disease pathogenesis. Data presented here demon-
strates that terminal ECF in both Holstein and Boran cattle is largely due to multisystemic
histiocytic responses and resultant tissue damage. Furthermore, the combination of these
histologic changes with the clinical findings, including lymphadenopathy, prolonged pyrexia,
multi-lineage leukopenia, and thrombocytopenia is consistent with macrophage activation
syndrome. All animals that succumbed to infection exhibited lymphohistiocytic vasculitis of
small to medium caliber blood and lymphatic vessels. In pulmonary, lymphoid, splenic and
hepatic tissues from Holstein cattle, the majority of intralesional macrophages were positive
for CD163, and often expressed large amounts of IL-17. These data define a terminal ECF
pathogenesis in which parasite-driven lymphoproliferation leads to secondary systemic
macrophage activation syndrome, mononuclear vasculitis, pulmonary edema, respiratory
failure and death. The accompanying macrophage phenotype defined by CD163 and IL-17
is presented in the context of this pathogenesis.
Introduction
Theileria parva is an intracellular apicomplexan parasite of Cape buffalo (Syncerus caffer) and
Bos indicus and Bos taurus cattle in sub-Saharan Africa. Mortality rates are high in most
PLOSONE | DOI:10.1371/journal.pone.0156004 May 19, 2016 1 / 20
a11111
OPEN ACCESS
Citation: Fry LM, Schneider DA, Frevert CW, Nelson
DD, Morrison WI, Knowles DP (2016) East Coast
Fever Caused by Theileria parva Is Characterized by
Macrophage Activation Associated with Vasculitis and
Respiratory Failure. PLoS ONE 11(5): e0156004.
doi:10.1371/journal.pone.0156004
Editor: Ilse D. Jacobsen, Leibniz Institute for Natural
Products Research and Infection Biology- Hans
Knoell Institute, GERMANY
Received: March 8, 2016
Accepted: May 6, 2016
Published: May 19, 2016
Copyright: This is an open access article, free of all
copyright, and may be freely reproduced, distributed,
transmitted, modified, built upon, or otherwise used
by anyone for any lawful purpose. The work is made
available under the Creative Commons CC0 public
domain dedication.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information files.
Funding: This work was supported by USAID AID-
BFS-P-13-00002 and the Bill and Melinda Gates
Foundation grant OPP1078791. The funders had no
role in study design, data collection and analysis,
decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared
that no competing interests exist.
imported Bos taurus breeds and indigenous breeds raised in non-endemic areas [1]. T. parva
kills over one million cattle each year in sub-Saharan Africa, resulting in severe economic dis-
advantage for pastoral farmers. Like the closely related protozoan pathogens Plasmodium and
Babesia, and the distantly related protozoan pathogens Trypanosoma and Leishmania, which
cause disease in animals and humans, T. parva is arthropod-borne.
T. parva is primarily transmitted by the three-host tick Rhipicephalus appendiculatus. Fol-
lowing transmission to cattle by infected ticks, sporozoites enter lymphocytes and mature into
multinucleated schizonts. Schizonts induce constitutive activation of multiple host-cell signal
transduction pathways, preventing apoptosis and causing cell transformation and marked lym-
phoproliferation [2–5]. Association of the schizont with the host cell mitotic spindle apparatus
allows the schizont to divide in concert with infected host cells, and also minimizes schizont
exposure to extracellular clearance mechanisms. Prior to data presented here, clinical disease,
including terminal ECF, was thought to be driven solely by lymphoproliferation and resultant
organ infiltration by infected, transformed lymphocytes.
Clinical disease (East Coast Fever) is characterized by marked peripheral lymphadenopathy,
fever, anorexia and respiratory distress. Small numbers of infected cattle develop neurologic
signs (turning sickness), due to blockage of cerebral vessels by clusters of parasitized cells.
Clinicopathologic changes described in end-stage disease include severe leukopenia, thrombo-
cytopenia, lymphocytolysis in lymphoid tissues and hemorrhage [6, 7]. The causes of leukope-
nia, which involves both lymphoid and myeloid cells, are unclear but likely include rupture of
infected lymphocytes during merozoite production, and lysis of uninfected cells in lymphoid
tissues. Treatment with antiparasitic drugs, such as buparvaquone early in the course of infec-
tion, can lessen disease severity, but does not always eliminate the parasite [8]. Immunization
of cattle by concurrent infection of cattle with live T. parva sporozoites and treatment with
long-acting oxytetracycline, known as the infection and treatment method (ITM) [9], results in
transient clinical reactions, apparently due to the impact of oxytetracycline on parasite replica-
tion. At least one T. parva strain included in the ITM cocktail results in long-term T. parva
infection [10].
Cattle that survive natural infections or are immunized using ITM develop solid immunity
to similar strains. In these animals, the protective immune response is largely mediated by
major histocompatibility complex (MHC) class I-restricted CD8+ cytotoxic T lymphocytes
(CTL) specific for T. parva schizont-infected lymphocytes [11] and is often strain-specific [12].
Cattle immunized using ITM also generate MHC class II-restricted CD4+ T cells specific for T.
parva schizont-infected lymphocytes [12, 13]. Like parasite-specific CTLs, parasite-specific
helper T cells are sometimes strain-specific [12].
Unfortunately, animals infected with T. parva, even with concurrent treatment, often fail to
control the parasite and succumb to severe ECF within three weeks of infection. Severely
affected cattle usually succumb to pulmonary edema [6]. Widespread tissue infiltration by
transformed lymphocytes, including infiltration of alveolar septae, has been documented by
histopathologic evaluation [6, 14–16]. These data led to the understanding that pulmonary
infiltration by transformed lymphocytes was associated with respiratory failure; however, past
histologic evaluation of affected tissues was limited.
As part of vaccine development efforts, infection and treatment experiments were initiated
to study development of immunity to T. parva. Despite intensive supportive care, a subset of
animals developed severe ECF intractable to treatment. To assure a complete understanding of
the disease pathogenesis, these animals were fully evaluated by necropsy, histopathology and
follow-up immunohistochemical (IHC) studies.
Two IHC studies on tissue from infected cattle have been published [17, 18], and support
previous histologic data that large numbers of T cells infiltrate the lungs of cattle with ECF.
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While our initial IHC analyses also demonstrate abundant T cells within the lungs of cattle, we
also documented a large population of CD3- and CD20-negative mononuclear cells within tis-
sues of affected cattle. Based on these studies, we hypothesized that histiocytic cells (cells of the
monocyte/macrophage lineage) play a role in the development of acute ECF in cattle. Histol-
ogy, IHC, and morphometry were used to garner an understanding of the role macrophages
play in the development of acute ECF.
Although some of the components of the immune response to T. parva are well-understood,
the pathogenesis of lethal disease, including the possible role of aberrant immune responses,
was hitherto largely unexplored. Since macrophages can serve both immunostimulatory and
immunosuppressive roles, and thus alter the efficacy and character of the adaptive immune
response, we also sought to provide initial characterization of the histiocytic response in T.
parva. CD163 is a macrophage scavenger receptor that is generally up-regulated in anti-inflam-
matory, immunosuppressive states, and also in response to severe tissue injury ([19, 20]). In
contrast, IL-17 is a pro-inflammatory cytokine produced by many leukocytes (including mac-
rophages) that is often associated with severe immunopathology ([21–23]). We used immuno-
histochemical labeling of CD163 and IL-17 to provide basic phenotypic information about the
macrophage response in T. parva. These data were coupled with clinical data to generate a
more detailed understanding of the immunopathogenesis of acute ECF.
Data presented here expand ECF pathogenesis to include a macrophage-centric inflamma-
tory response. While a robust innate immune response is likely required to trigger a disease-
limiting adaptive immune response to T. parva, excessive macrophage activation and resultant
tissue destruction likely trigger ECF. Importantly, infection with lethal doses of T. parva was
found to cause severe lymphohistiocytic vasculitis of the lungs, lymph nodes, spleen and liver,
and these organs were shown to contain large numbers of CD163+ and IL-17+ macrophages.
We propose that pulmonary edema and respiratory failure during ECF are due to the develop-
ment of pulmonary vasculitis, and that the induction of a multisystemic histiocytic response
contributes significantly to clinical disease in ECF.
Materials and Methods
Holstein cattle (Bos taurus)
All animal experiments were approved by the Washington State University and University of
Idaho Institutional Animal Care and Use Committees, protocol numbers 2013–66 (U of I) and
04515–002 (WSU). All therapeutic drugs were administered according to the manufacturer’s
dosing instructions. This study utilized eight, three month-old Holstein steers from dairies in
northern Idaho and central Washington. These cattle were acquired for initiation of vaccine
development studies. Cattle were quarantined at the USDA-ARS-ADRU vector disease
research barns for two weeks before the onset of the study, and received regular health checks
from a licensed veterinarian at this time. Pre-infection complete blood counts (CBCs) and
serum chemistry panels were normal. After quarantine, calves were housed in pairs in
box stalls in the USDA-ARS-ADRU vector disease research barn. Stalls were bedded with
wood shavings. Animals had continuous access to fresh water and were fed grass and alfalfa
hay and a small amount of Calf Manna (MannaPro1, USA) twice daily. Mechanical heating
and cooling units, coupled with open-air ventilation were used to maintain the barn at approxi-
mately 16°C. Calves were exposed to overhead lighting from 7 a.m. to 5 p.m. daily, and were
closely monitored by animal care staff and veterinarians.
Five animals were infected with T. parva via subcutaneous injection of 0.2–0.5 mL of cryo-
preserved T. parvaMuguga sporozoite stabilate Ed80 in the left parotid region. Three unin-
fected animals were maintained as negative controls. Following infection, complete physical
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examination, including rectal temperature, palpation of peripheral lymph nodes and thoracic
auscultation, was performed on each animal at least once per day. At the onset of pyrexia (rec-
tal temperature 39.4°C), CBCs were performed regularly to monitor leukocyte, erythrocyte,
and platelet counts. As soon as peripheral lymph node enlargement was detected, needle aspi-
rates were collected from affected nodes once daily, and Giemsa-stained smears of aspirates
examined for schizont-infected lymphocytes.
Two animals were co-treated with Liquamycin1 (Zoetis, USA), a long-acting form of oxy-
tetracycline (LA OTC) at the time of infection. In the three remaining calves, Terramycin1
(Zoetis, USA), a short-acting oxytetracycline (SA OTC) was administered intramuscularly
every 24 hours after the onset of pyrexia in an attempt to curtail schizont parasitemia. In all
calves, pyrexia was controlled via parenteral administration of flunixin meglumine (Pfizer Ani-
mal Health, USA), and anorexic calves were given Resorb1 (Zoetis, USA) oral electrolyte solu-
tion three times a day. If animals developed dyspnea or tachypnea, furosemide (Bayer
Healthcare, USA) was administered via intramuscular injection to decrease pulmonary edema.
Buparvaquone (Bimeda, Ireland) was administered via intramuscular injection every 48 hours
to aid in controlling disease in two calves.
Three inoculated calves developed severe dyspnea that failed to respond to the aforemen-
tioned treatment protocols and were euthanized via intravenous injection of Fatal Plus (Vor-
tech Pharmaceuticals, USA), and one calf died suddenly of respiratory failure just before
euthanasia could be administered. In each case, a complete necropsy was performed within
twelve hours of death. Table 1 summarizes information on each infected Holstein calf included
in this study.
Histopathology and immunohistochemistry, Holstein cattle
Tissue sections were fixed in 10% neutral buffered formalin for at least seven days. For basic
histopathology, formalin-fixed sections of lung, lymph node, heart, liver, spleen, kidney, adre-
nal gland, forestomachs, intestines, brain and pituitary gland were trimmed, routinely pro-
cessed, stained with hematoxylin and eosin (H&E), and examined with a light microscope.
Immunophenotyping of the leukocyte infiltrates was performed using immunohistochemical
(IHC) detection of CD3 (T cell marker [24]), CD20 (B cell marker [25]), IBA-1 (pan-histiocytic
(monocyte/macrophage/dendritic cell) marker [26, 27]), CD163 (macrophage marker [28]),
and, due to recent studies on its importance in lesion development in several protozoal infec-
tions, interleukin-17 [21–23, 29]. Detection of T. parva schizonts was performed using a mono-
clonal antibody to the T. parva schizont surface-bound polymorphic immunodominant
molecule (PIM) antigen [18, 30]. The species of origin, isotype, source, concentration, and
Antibody Registry numbers (where applicable) of the primary antibodies used in this study are
provided in Table 2.
For all IHC, 2–3 μm thick serial sections of formalin-fixed, paraffin-embedded tissues were
placed onto positively charged glass slides (Superfrost1/Plus, Fisher Scientific, Pittsburg, PA).
Table 1. Animal Identification, Infection, Treatment and Outcome.
Animal Number Stabilate Dose (mL) Antibiotic Treatment Buparvaquone Outcome
1412 0.5 LA OTC, ITM Yes Survived
1415 0.3 LA OTC, ITM Yes Euthanized
1419 0.2 SA OTC No Euthanized
1420 0.2 SA OTC No Died
1435 0.2 SA OTC No Euthanized
doi:10.1371/journal.pone.0156004.t001
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An automated processor (Discovery XT, Ventana Medical Systems,Tucson, AZ) was used for
deparaffinization, antigen retrieval and immunolabeling. For single immunolabeling, sections
were incubated with the primary antibody for two hours, followed by the Ventana universal
secondary antibody and detection with the Discovery DAB1 (3,3’–diaminobenzadine chro-
magen) Map Kit (Ventana). For double-labeling studies, sections were then incubated with the
second primary antibody for three hours, followed by the Ventana universal secondary anti-
body and detection with the Discovery1 RedMap (Red/Napthol chromagen) Kit (Ventana).
All slides were then counterstained with hematoxylin, and evaluated using a light microscope.
Immunostaining of tissues from an uninfected calf, as well as incubation of tissues with irrele-
vant, isotype-matched primary antibodies or substitution of primary and secondary antibodies
with antibody diluent were used as controls in all reactions.
Fluorescent Immunohistochemical Co-Labeling
Thin section deparaffinization, antigen retrieval and fluorescence immunohistochemistry were
performed using the automated slide staining platform, Discovery XT (Ventana Medical Sys-
tems). Following extended deparaffinization (75°C), epitope retrieval was achieved using a tris-
based buffer, pH 8.5, (Cell Conditioning Solution CC1, Ventana Medical Systems) held at 95°C
for ~60 minutes (“standard cell conditioning” protocol). Thereafter, the sequence of automated
protocol steps for dual immunofluorescence labeling were: antibody blocking, application of
1st primary antibody and detection steps using tyramide-FITC signal amplification (RUO anti-
Rabbit or anti-Mouse IgG FITC, Ventana Medical Systems), denaturation (32 minutes at
95°C), application of 2nd primary antibody and detection steps using Goat anti-Rabbit or anti-
Mouse IgG conjugated to AlexaFluor 647 (Invitrogen).
Dual labeling was performed to detect cells co-expressing IL-17 (1st primary antibody, 4
hours incubation, Table 2) and each of the cell lineage markers CD3, CD163, and IBA-1 (2nd
primary antibodies, 12 hours incubation, Table 2). Control reactions included substitution of
the 1st primary with 10 μg/mL Rabbit non-immune serum (Dako), the 2nd primary with 6 μg/
mL Rabbit non-immune serum or 2.5 μg/mL of a Mouse monoclonal IgG1 irrelevant epitope
antibody. No fluorescence bleed through or cross-reactivity were observed in these control
reactions.
Dual labeling of CD163 and IBA-1 was conducted as above for IBA-1 (2 μg/mL) as the 2nd
primary antibody, but substituting MCA1853 (1 μg/mL, 2 hour incubation) as the 1st primary
antibody. No fluorescence bleed through or cross-reactivity were observed when substituting
1 μg/mL of a Mouse monoclonal IgG1 irrelevant epitope antibody as the 1st primary antibody
or 2 μg/mL Rabbit non-immune serum as the 2nd primary antibody.
Epifluorescence microscopy was conducted using an Axio Imager.M1 microscope (Carl
Zeiss Microimaging, Thornwood, NY) equipped with an X-Cite 120 Fl Illuminating system
(EXFO Photonic Solutions, Mississauga, Ontario, Canada), an AxioCamMRm digital camera,
Table 2. Antibodies used for IHC and Fluorescent Co-Labeling IHC.
Target Name Species and Isotype Concentration (μg/mL) Source Antibody Registry ID
CD3 A0452 Rabbit, polyclonal 6 Dako AB_2335677
CD20 Rb9013 Rabbit, polyclonal 0.13 Neomarkers AB_149765
CD163 MCA1853 Mouse, IgG1 2.5 Serotec AB_2074540
IBA-1 IBA-1 Rabbit, polyclonal 2 Wako AB_839504
IL-17 Ab79056 Rabbit, IgG 10 AbCam AB_1603584
PIM ILS-40 Mouse, IgG 3.1 Ivan Morrison
doi:10.1371/journal.pone.0156004.t002
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and a computer workstation running AxioVision 4.8.1 imaging software. Fluorescence images
were captured as a z-stack (step increment 275 nm) using an EC Plan-Neofluar 40x/1.3 oil
M27 objective. Maximum intensity projections of z-stack images were processed using Fiji (an
ImageJ-based open source image processing package) and figures organized using Photoshop
Elements software.
Boran Cattle (Bos indicus)
H&E stained sections of the left pre-scapular lymph nodes from twenty African Boran calves
were evaluated. All cattle were used in an ECF infection kinetics study at the International Live-
stock Research Institute in Nairobi, Kenya in 1981 [31]. In the study, 17/20 cattle were infected
with a lethal dose of T. parvaMuguga, and three calves were used as negative controls. Following
infection, pairs of cattle were euthanized on days 3, 6, 8, 10, 12, 14, and 16 days post infection. Of
the remaining three infected animals, one was euthanized on day 18, one on day 19, and one ani-
mal succumbed to ECF on day 19. The negative control animals were euthanized at the end of
the experiment. Lymph nodes were collected during postmortem examination, fixed in 10% neu-
tral buffered formalin, and routinely processed for histopathology. Slides were stored until 2014
by Dr. Ivan Morrison, and were shipped to Pullman, WA for histologic evaluation.
Morphometric Measurements of Lungs
To provide quantitative measurements of CD163, IBA-1 and IL-17 positive staining in lung tis-
sue, whole slide digital images were collected and automated image analysis performed. Briefly,
sections of lung from infected and control animals immunohistochemically labelled for IBA-1,
CD163, and IL-17 as described above were scanned in bright field with a 20X objective using a
Nanozoomer Digital Pathology slide scanner (Hamamatsu; Bridgewater, New Jersey). The
whole slide digital images were then imported into Visiopharm software (Hoersholm, Den-
mark) for analysis. The Visiopharm Image Analysis module automatically detected tissue on
slides, from which sections of lung were selected. For each marker, 184–234 mm2 of control
calf lung tissue was analyzed and 497–625 mm2 of infected calf lung tissue was analyzed. 100%
of each lung section was analyzed. Digital images were converted to gray scale values using
RGB-R and RGB-B filters with a mean size of 5 pixels by 5 pixels. Visiopharm was trained to
label positively stained cells for CD163, IBA-1 and IL17, and to detect background tissue
counter stain (Hematoxylin) using an analyte-specific configuration based on a threshold of
pixel values. Images were processed in batch mode using the configuration developed for each
analyte to generate the desired outputs. For each analyte, the following were calculated: A. Area
of positive immunolabeling, B. Area of hematoxylin stained tissue, C. Total area of tissue
(A+B), and D. Ratio of positive analyte staining to total tissue area (A/C). Any non-specific
staining (e.g., staining along the edge of tissues) on tissue sections or any tissue that showed
substantial damage from processing was excluded from analysis. Based on output for each sec-
tion analyzed, the mean value for each analyte was calculated by averaging the results obtained
from each animal and then averaging the results for the control cattle and cattle infected with
T. parva. Mean values for control and infected groups were compared using a one-tailed stu-
dent’s t-test (α<0.05).
Results
Clinical disease kinetics of ECF in Holstein calves
Left parotid lymphadenopathy was noted 4–7 days post infection, and enlargement of contra-
lateral and other regional lymph nodes developed by day 9. Schizonts were detected in Giemsa-
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stained aspirates of the left parotid lymph node within 24 hours of the development of lymph-
adenopathy, and the percentage of schizont-positive, blasting lymphocytes ranged from 9%-
34% during acute disease. Large numbers of uninfected lymphoblasts were also detected in all
aspirates. All cattle exhibited severe, sustained pyrexia (39.5–41.6°C) from 6–9 days post infec-
tion onward. Resting respiratory rates in all calves began to increase between days 6 and 11
post-infection, and cattle exhibited terminal dyspnea characterized by neck extension, rapid,
shallow inspiration and marked expiratory effort consistent with restrictive pulmonary disease.
During this time, crackles were auscultated over all lung fields. Between days 10 and 15, four of
five animals developed petechiae over the gingival and scleral mucosae. Over the course of
acute disease, the body weight of all animals decreased 25%-33%, and calves exhibited
decreased skeletal muscle mass and increased skeletal prominence. Similar clinical reactions
were observed in the Boran cattle used in the ECF infection kinetics study at ILRI in 1981
(Morrison, et al., 1981).
From day 8–11 post infection, total leukocyte counts dropped significantly, with nadirs of
300–3000 leukocytes/μL of blood (normal 4,000–12,000/μL). Both neutrophil and lymphocyte
subsets were affected; however, neutropenia was far more severe than lymphopenia in all ani-
mals. The Boran cattle infected at ILRI in 1981 also developed severe terminal leukopenia [31].
In our study, four calves developed severe thrombocytopenia, with nadirs of 42,000–59,000
platelets/μL of blood (normal 100,000–700,000/μL). The development of thrombocytopenia
corresponded to the development of mucosal petechiation. Terminally, three calves (1415,
1419, and 1435) developed mild anemia (PCV 21%-23%, pre-infection PCV for these calves
was 29%-31%), and all animals developed moderate hypoproteinemia. Beginning seven days
post infection, schizont-infected lymphoblasts were consistently detected on Giemsa-stained
blood smears; however, merozoite infected erythrocytes were rarely detected. Sustained, mod-
erate liver enzyme elevations were noted in two of five (1415 and 1412) animals from day
seven post infection onward.
Gross Lesions of ECF in Holstein calves
Necropsy findings were similar in all animals. The pleural, pericardial, and peritoneal cavities
contained abundant free serosanguinous fluid (S1 Fig), and petechiae and ecchymoses were
disseminated across the epicardium, tracheal mucosa, visceral pleura, and serosa of the foresto-
machs, and intestines. All animals had severe interstitial pneumonia affecting all lung lobes, as
well as severe pulmonary edema, with expansion of interlobular septae and abundant foam
within the airways (S2 Fig). Bilaterally, the retropharyngeal, parotid, cervical, prescapular, tra-
cheobronchial, pre-hepatic and sublumbar lymph nodes were enlarged to 2–20 times normal
size. On cut surface, enlarged nodes were edematous, and contained large foci of hemorrhage
and necrosis. Two animals (1415 and 1420) had severe, subcutaneous intermandibular edema.
Calf 1415 also had severe fibrinosuppurative tracheitis and bronchopneumonia (secondary
bacterial infection).
Histopathologic lesions of ECF in Boran and Holstein calves
In order to provide a more comprehensive understanding of ECF pathogenesis, histologic eval-
uation of the lungs, lymph nodes, spleen, liver, heart, brain, and intestines of Holstein calves
with terminal ECF was performed. In multiple foci throughout the lungs of all calves, small to
medium caliber blood and lymphatic vessel walls were severely disrupted by fibrinoid degener-
ation, necrotic cellular debris, edema, and macrophages and lymphocytes (mononuclear vascu-
litis). Affected vessels were lined by reactive endothelial cells, and clusters of monocytes were
frequently adhered to the luminal aspect of the endothelium. In general, thin-walled veins and
Theileria parva Innate Immunity and Immunopathology
PLOS ONE | DOI:10.1371/journal.pone.0156004 May 19, 2016 7 / 20
lymphatic vessels were more severely affected than arterioles. Alveoli and interlobular septae
were filled with and widened by edema, fibrin, hemorrhage, and alveolar macrophages, and
alveolar septae were markedly widened by fibrin mats and infiltrating macrophages and lym-
phocytes (Fig 1).
Within lymph nodes, corticomedullary distinction was largely lost, and normal architecture
replaced by sheets of macrophages and lymphoblasts separated by large aggregates of necrotic
cells, fibrin and hemorrhage. As in the lungs, small to medium caliber blood and lymphatic ves-
sels within lymph nodes were often disrupted by vasculitis. Lymph nodes draining the site of
infection were most severely affected (Fig 1).
Fig 1. Histologic Lesions in Holstein and Boran cattle.Representative photomicrographs of H&E stained sections of lymph
node medulla in uninfected control and infected Boran (day 12) and Holstein calves, and lung from uninfected control and
infected Holstein calves. Note: Severe disruption of vessel walls by mononuclear cells and fibrinoid degeneration (lung and
lymph node), and lymphohistiocytic interstitial pneumonia with edema (lung). Scale bar: 200 μm.
doi:10.1371/journal.pone.0156004.g001
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Hepatic portal triads were rimmed by moderate to large numbers of macrophages and lym-
phoblasts, and portal vessels were multifocally, mildly disrupted by vasculitis.
Within the spleen, the distinction between the red and white pulp was often unapparent. In
some foci, periarteriolar lymphatic sheaths were often greatly expanded by monomorphic pop-
ulations of lymphoblasts or replaced by sheets of macrophages. Numerous macrophages were
filled with hemosiderin, suggesting increased erythrocyte turnover and erythrophagocytosis.
In order to establish a kinetic framework for the development of histologic lesions in ECF,
sections of lymph nodes collected from Boran cattle at regular intervals following T. parva
infection were examined and compared. Within these sections, mild vasculitic lesions were evi-
dent as early as three days post infection. From day 10 to 19, severe lymphoid necrosis, edema
and hemorrhage developed within affected nodes. During this time period, vasculitis lesions
became more prevalent and more severe, with marked fibrinoid degeneration, endothelial dis-
ruption, and fibrin thrombus formation observed in the majority of vessels by day 19. Repre-
sentative histologic lesions are shown in Fig 1.
Tissue distribution of T. parva infected cells
In all infected animals, large numbers of schizont-infected cells were detected within the lungs,
lymph nodes, spleen, liver, and bone marrow, and rare infected cells were detected within the
brain, adrenal glands, thyroid gland, heart, and tongue. Schizont-infected cells were most prev-
alent in the spleen (Fig 2), and were widely dispersed throughout the red and white pulp.
Within the lungs, infected cells infiltrated interlobular and alveolar septae, and were occasion-
ally within perivascular connective tissue and vessel walls. Infected cells were within the cortex
and medulla of lymph nodes, and often surrounded portal vessels within the liver. No staining
with the anti-schizont antibody was detected in tissues from an uninfected control calf.
Immunohistochemical characterization of mononuclear cell tissue
infiltrates
In all animals, the lungs, lymph nodes, spleen, and liver contained markedly increased numbers
of T cells (CD3+ cells); however, B cells (CD20+ cells) were rarely detected within the lungs
Fig 2. Splenic PIM Immunoreactivity. Shown are the results of immunohistochemical labeling of the T. parva antigen, PIM, in the spleen. A. The
spleen of the control calf lacks PIM immunoreactivity. B. In a representative infected Holstein calf, there is abundant PIM immunoreactivity within
lymphocytes of the red and white pulp. Scale bar: 200 μm.
doi:10.1371/journal.pone.0156004.g002
Theileria parva Innate Immunity and Immunopathology
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Fig 3. Immunohistochemical Labeling of Leukocytes in the Lungs. Shown are the results of IHC labeling for CD3-like
immunoreactivity (CD3-li), CD163-li, IBA-1-li, and IL-17-li in the lung of uninfected control and representative infected Holstein calves.
Theileria parva Innate Immunity and Immunopathology
PLOS ONE | DOI:10.1371/journal.pone.0156004 May 19, 2016 10 / 20
and liver, and were greatly decreased within the spleen and lymph nodes (S3 Fig). Within the
lungs, T cells were found within interlobular and alveolar septae, within perivascular connec-
tive tissue, and within vessel walls and lumina (Fig 3). Large sheets of blastic T cells expanded
the red and white pulp of the spleen and the cortex and medulla of lymph nodes, and were
often detected within vessel walls of both organs. T-cells expanded the periportal space within
the liver.
The lungs, lymph nodes, spleen, and liver of all infected animals contained large numbers of
IBA-1 positive (histiocytic) cells. Within the lungs of infected animals, large numbers of mac-
rophages infiltrated vessel walls, alveolar septae, alveoli, and interlobular septae, and large clus-
ters of macrophages were often adhered to the endothelium of small to medium caliber vessels.
In lung sections from the control animals, normal alveolar macrophages were observed in the
alveolar septae. In the lymph nodes of infected calves, large sheets of macrophages obscured
normal corticomedullary architecture, disrupted vessel walls, and partially occluded vessels. In
lymph nodes from the infected calf, macrophages were confined to the subcapsular and medul-
lary sinuses. Within infected animals, but not uninfected controls, sheets of macrophages mul-
tifocally disrupted the red and white pulp of the spleen, and small to moderate numbers of
macrophages were mixed with lymphocytes in periportal areas of the liver. Further sub-typing
of macrophage populations using CD163 labeling revealed that the vast majority of tissue-asso-
ciated macrophages within infected animals were CD163+ (Fig 3). The mean percent sectional
area positive for CD163 and IBA-1 in lung sections from T. parva infected and control calves is
listed in Table 3. The mean percent sectional area positive for CD163 was significantly greater
in the T. parva infected calves than in the control calves (p = 0.005). This finding supports the
histologic impression that the lungs of infected calves contain larger numbers of CD163+ mac-
rophages than those of the control calves. Although the CD163+ macrophage subset is
increased in the lung during acute ECF, there was no significant difference in total histiocytic
cell (IBA-1 positive) sectional area in T. parva infected animals and control animals (p = 0.28).
Expression of IL-17 by macrophages
In all infected animals, the lungs, lymph nodes, spleen, and liver contained large numbers of
IL-17-positive mononuclear leukocytes. Within the lungs, IL-17-positive cells were found
within alveolar and interlobular septae, alveoli, and within vessel walls and vasculitic lesions
(Fig 3). Sheets of IL-17-positive cells were most abundant within the subcapsular and medul-
lary sinuses of lymph nodes, and small numbers of IL-17-positive cells were found within the
superficial cortex. IL-17-positive cells were often found within periportal regions of the liver,
and scattered throughout sheets of macrophages within the spleen. Importantly, vascular
Note: CD3-li, CD163-li, and IL-17-li is significantly increased in the lungs of the infected calf. Furthermore, CD3+, CD163+, IBA-1+ and
IL-17+ mononuclear cells are components of vasculitis lesions. Vascular endothelial cells consistently exhibit pronounced IL-17-li in the
infected calf, but endothelial IL-17-li is rare in the control calf. Scale bar: 200 μm.
doi:10.1371/journal.pone.0156004.g003
Table 3. Mean Sectional Area Positive for CD163, IBA-1, and IL-17.
Marker Mean Sectional Area Positive p Value
Infected (n = 4) Control (n = 3)
CD163 23.02% 8.97% 0.005
IBA-1 26.28% 22.61% 0.28
IL-17 24.77% 7.5% 0.01
doi:10.1371/journal.pone.0156004.t003
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endothelial cells were frequently strongly positive for IL-17 (Fig 3). Non-cell associated IL-17
staining was frequently observed within mats of fibrin and within connective tissue of vessel
walls. The mean percent sectional area positive for IL-17 in lung sections from T. parva
infected and control calves is listed in Table 3. The mean sectional area positive for IL-17
within the lungs of T. parva infected cattle was significantly greater than that in the control cat-
tle (p = 0.01).
Within the lymph nodes and lungs of both the infected and control calves, almost all IL-
17-positive mononuclear cells were co-positive for IBA-1, and only rarely co-positive for CD3,
suggesting that, in acute T. parva infection, IL-17 is produced predominantly by macrophages
(Fig 4). Interestingly, in all calves, the majority of IL-17-positive macrophages co-expressed
CD163 (Fig 4). The number of IL-17-positive cells was significantly greater in the infected
calves than in the control cattle. Since CD163 is only expressed on a subset of macrophages,
and is up-regulated in actively phagocytic cells, we performed co-labeling studies using IBA-1
and CD163. As expected, all CD163-positive cells were also positive for IBA-1, but only a sub-
set of IBA-1 positive cells were also positive for CD163 (Fig 5). In the infected cattle, a subjec-
tively larger proportion of IBA-1-positive (histiocytic) cells co-expressed CD163 than in the
control cattle.
Discussion
The results of this study provide new insights into the immunopathogenesis of acute, fatal
ECF. Protozoa—including Plasmodium sp., Trypanosoma sp., and Toxoplasma sp., are adept at
immune system subversion, and numerous pathogen-mediated forms of immune evasion—
such as antigenic variation, limited antigen production, persistence in immune-privileged sites,
and altered antigen presentation have been described in protozoal infections [32–35]. Protozoa
have also been shown to subvert T-cell responses by triggering anergy, exhaustion, or apoptosis
[36]. Another mechanism of T-cell inhibition in protozoal disease is the induction of alterna-
tively activated, or suppressor, macrophages [37]. Although definitive phenotypic characteriza-
tion of macrophage subsets in situ is difficult because gene expression in macrophages is highly
plastic and changes with fluctuating environmental cues [38], alternatively activated macro-
phages in humans and mice are often characterized by high expression of CD163 [37].
CD163 is a membrane-bound, hemoglobin/haptoglobin scavenger receptor protein in the
scavenger receptor cysteine-rich superfamily group B [39]. Hemoglobin is released from dam-
aged erythrocytes, and can cause oxidative damage to cells. After binding to CD163, hemoglo-
bin is degraded within the macrophage, and several anti-inflammatory substances are released
[40, 41]. In addition to its scavenger receptor role, CD163 can also bind bacteria and viruses,
and its expression is up-regulated on mature, actively phagocytic tissue macrophages [19]. In
general, CD163 expression is up-regulated by glucocorticoids and IL-10, and down-regulated
by pro-inflammatory cytokines, including IFN-γ [20].
In infectious disease, alternatively activated macrophages have been shown to suppress T-
cell activation. The presence of CD163+ macrophages is associated with increased tissue
Fig 4. Dual Fluorescence Labeling of Leukocytes in Lymph Nodes. Shown are the results of dual
fluorescence labeling for IL-17-li (pseudocolored cyan) and either CD3-, IBA-1-, or CD163-li (pseudocolored
magenta) in the medulla of a lymph node from a control calf and representative infected calves. Note: IL-17-li
was infrequent in the medulla of control calf lymph node but was widespread throughout the medulla of
infected calves. Where it occurred within the non-vascular elements, IL-17-li was generally punctate and
appeared intracellular. The cell-associated, punctate IL-17-li was considerably weaker in intensity and less
dense as compared to the infected calves. In both the infected calves and, where present, in the control calf,
intracellular punctate IL-17-li was most frequently co-localized with IBA-1-li cells and CD163-li cells but not
with CD3-li cells. Scale bar: 20 μm.
doi:10.1371/journal.pone.0156004.g004
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invasion, decreased T-cell activity, and resultant poor prognosis in many forms of human can-
cer [42, 43], and alternatively activated macrophages are associated with altered T-cell function
Fig 5. CD163 and IBA-1 Dual Fluorescence Labeling. Shown are the results of dual fluorescence labeling for
CD163-li (pseudocolored cyan) and IBA-1-li (pseudocolored magenta) in a lymph node cortical follicle and medulla from
the control calf and representative infected calves. In both calves, most CD163-li cells were co-labeled by IBA-1-li but
not all IBA-li cells were co-labeled with CD163-li. IBA-1-li cells without definitive CD163-li were most frequent in the
control calf lymph parafollicular regions. Scale bar: 20 μm.
doi:10.1371/journal.pone.0156004.g005
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and parasite persistence in trypanosomiasis [44–46] and toxoplasmosis [47]. It is possible that
lysis of T. parva infected lymphocytes and erythrocytes, and the resulting free iron and pro-
inflammatory milieu of necrosis stimulates a robust CD163+macrophage response in acute T.
parva. The presence of large numbers of CD163+macrophages, could, in turn, inhibit necessary
proliferative and cytotoxic T-cell responses. Alternatively, since T. parva infected lymphocytes
have been shown to produce significant amounts of IL-10 [48], it is possible that schizont-
infected lymphocytes themselves stimulate a CD163 macrophage response in acute ECF.
Robust CD163+ macrophage responses are also observed in macrophage activation syn-
drome (MAS, also referred to as hemophagocytic lymphohistioctyosis), an exaggerated sys-
temic macrophage response observed in numerous neoplastic, autoimmune, and infectious
diseases [49], including trypanosomiasis in cattle [50]. Clinical components of MAS include
prolonged fever, lymphadenomegaly, splenomegaly, hemorrhage, cytopenias that affect at least
two leukocyte lineages, thrombocytopenia, hypoproteinemia, elevated liver enzymes, hemo-
phagocytosis, tissue infiltration by activated macrophages, hyperferritinemia, and elevated sol-
uble CD163 (sCD163) [51]. CD163 is cleaved from the membrane of macrophages in response
to severe inflammation, exposure to LPS, and cross linkage of FC receptors [19]. In humans
and mice, serum levels of sCD163 increase markedly during acute inflammation, and serve as a
means of monitoring macrophage activation [52, 53].
The cattle in this study demonstrated several of the hallmark criteria of MAS, including
fever, lymphadenomegaly, hemorrhage, panleukopenia, thrombocytopenia, hypoproteinemia,
elevated liver enzymes, and infiltration of numerous tissues by macrophages. Consistent with
MAS, the spleens of these cattle contained increased numbers of macrophages, the majority of
which were CD163+. Many macrophages contained hemosiderin pigment, which is consistent
with hemophagocytosis and increased erythrocyte turnover. Large numbers of schizont-
infected lymphocytes were present in the spleens of the animals. Elucidation of the direct effect
of schizont-infected lymphocytes on macrophage induction in acute ECF requires further
study. As assays do not yet exist to quantify soluble CD163 in the serum of cattle, we were
unable to measure sCD163 in this study.
Interestingly, many of the CD163+ macrophages also exhibited positive immunolabeling
for IL-17, a pro-inflammatory cytokine. CD163 is considered a multifunctional receptor, and
thus, CD163+ macrophages often serve multiple, disparate functions [19]. Monoclonal anti-
body binding to CD163 caused production of pro-inflammatory cytokines in rats [54], and
engagement of CD163 by bacteria also led to pro-inflammatory cytokine production [55].
Thus, CD163+ cells may play myriad immunomodulatory roles throughout the disease course
in ECF.
It is likely that the marked macrophage-mediated IL-17 response contributes significantly
to the development of severe lesions in fatal ECF. In many protozoal infections, including
Leishmania major [21], Toxoplasma gondii [23] and Eimeria tenella [22], severe tissue damage
is associated with an overly robust IL-17 response, and can often be abrogated by administra-
tion of anti-IL-17 antibodies [22].
IL-17 can be produced by many leukocyte subsets, including Th17 CD4+ cells, CD8+ T
cells, γδ T cells, macrophages, dendritic cells and NK cells [56], and acts on many cell types,
including leukocytes, endothelial cells, epithelial cells, chondrocytes, osteoclasts, and fibro-
blasts. Binding of IL-17 to the IL-17 receptor leads to activation of MAP-kinase, NF-κB, and C/
EBPβ pathways, leading to production of numerous chemokines, cell adhesion molecules,
matrix metalloproteinases, and antimicrobial substances [57]. In psoriasis, activation of ERK
and MAP kinases after IL-17 binding to endothelial cells leads to increased cell adhesion mole-
cule and chemokine expression and vascular inflammation [58]. IL-17 production is also a
component of giant cell arteritis, and is believed to exert its effects on endothelial cells and
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fibroblasts within vessels, leading to endothelial cell activation, increased expression of adhe-
sion molecules and cytokines, recruitment of mononuclear cells, and vascular damage [59, 60].
In this study, endothelial cells were strongly positive for IL-17, suggesting that IL-17 produced
by leukocytes in the affected tissues was binding to endothelial cells. Downstream effects of IL-
17 binding to endothelial cells likely gave rise to the severe vasculitis noted in many tissues in
these calves.
Significantly, the most severe vasculitic lesions were present within the lungs of both Boran
and Holstein calves, suggesting that the pathogenesis of ECF is the same in both Bos indicus
and Bos taurus cattle. Inflammation of pulmonary blood and lymphatic vessels is the cause of
terminal pulmonary edema in ECF. In this, vasculitis leads to leakage of protein-rich fluid into
the airways and pleural space, causing severe restrictive and obstructive respiratory distress,
hypoxia, and death. The histological and immunohistochemical findings of this study further
suggest Theileria parva infection triggers macrophage activation syndrome and IL-17 produc-
tion leading to the development of vasculitis.
Future work will be undertaken to determine the cellular mechanisms of macrophage acti-
vation and the effect of CD163+ macrophages on T-cell function. This enhanced understand-
ing of the role of the innate immune response in T. parva, and its subsequent effect on the
trajectory of the adaptive immune response, will aid in the development of a vaccine that elicits
an efficacious cytotoxic T-cell response without causing severe immunopathology. Further-
more, the results of this study suggest that immunosuppressive drug therapy or anti-IL-17
therapy may provide clinical benefit to cattle with ECF.
Supporting Information
S1 Fig. Severe Pleural and Peritoneal Effusion, Calf 1435. In all deceased calves, large
amounts of free pleural and peritoneal fluid was noted during the gross exam.
(TIF)
S2 Fig. Severe Interstitial Pneumonia and Pulmonary Edema, Calf 1435. In all deceased
calves, lungs were reddened, wet, and heavy, and there was marked expansion of interlobular
septae by edema.
(TIF)
S3 Fig. CD20 Immunohistochemical Labeling in the Lungs. In all cattle, CD20-positive cells
(B lymphocytes) were rare in the lungs. Depicted is part of a normal bronchiolar associated
lymphoid follicle. Note the lack of B lymphocytes within alveolar septae, vessel walls, and vessel
lumina. Scale bar = 200 μm.
(TIF)
S1 Table. Raw Morphometric Data, IL-17.
(XLSX)
S2 Table. Raw Morphometric Data, IBA-1.
(XLSX)
S3 Table. Raw Morphometric Data, CD163.
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